Principal Financial Group
PASG icon

Principal Financial Group’s Passage Bio PASG Stock Holding History

Principal Financial Group’s Portfolio PASG Stock Details PASG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-526
Closed -$105K – 2599
2021
Q3 		$105K Sell
526
-85
-14% -$20.3K ﹤0.01% 2497
2021
Q2 		$162K Buy
+611
New +$189K ﹤0.01% 2493

Other funds holding PASG

O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
FM
Frazier Management Seattle, Washington $1.12M AUM 151.58% 1-Year Est. Return
VVM
Versant Venture Management San Francisco, California $141M AUM 190.82% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
NLVP
New Leaf Venture Partners New York $43M AUM 25.55% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Principal Financial Group's PASG Position: Q4 2021 in Review

Principal Financial Group sold out of Passage Bio (PASG) in Q4 2021, closing a stake of 526 shares — an estimated $105K sold.

Principal Financial Group first reported a position in PASG in Q2 2021 and held it in 2 quarters. The position peaked at $162K in Q2 2021. 99 funds tracked by Wall St. Rank hold PASG as of Q4 2021.

  • Principal Financial Group reported no remaining Passage Bio position as of Q4 2021 after selling out during the quarter.
  • Principal Financial Group sold 526 Passage Bio shares in Q4 2021, an estimated $105K.
  • Principal Financial Group first reported a position in Passage Bio in Q2 2021 and held it in 2 quarters.
  • Principal Financial Group's Passage Bio position peaked at $162K in Q2 2021.
  • 99 funds tracked by Wall St. Rank held Passage Bio as of Q4 2021.

Based on Principal Financial Group's 13F filing for Q4 2021, filed 9 Feb 2022.